Fasciola antigens as vaccines against fascioliasis and schistosomiasis |
| |
Authors: | Hillyer G V |
| |
Affiliation: | Department of Pathology and Laboratory Medicine, University of Puerto Rico School of Medicine, San Juan PR 00936-5067, Puerto Rico. ghillyer@rcm.upr.edu |
| |
Abstract: | Fascioliasis is an important trematode infection of herbivores worldwide with increasing evidence of prevalence as a disease of humans. Vaccination studies with purified native and recombinant Fasciola antigens suggest that this approach to diminished morbidity and mortality and reduced transmission is a realistic goal. Among the major potential vaccine candidates are fatty acid binding protein (FABP), cysteine (cathepsin) proteases, haemoglobulin, leucine aminopeptidase, and a saposin-like protein. In the case of Fasciola hepatica FABP, cross-reaction and cross-protection against Schistosoma mansoni is an important feature. In addition to protective effects with significant worm burden reductions, some vaccine candidates also have anti-fecundity (smaller flukes), anti-pathology (less liver lesions), and anti-embryonation effects. Optimism is tempered by the fact that fascioliasis in humans is an orphan disease and in need of governmental and foundation support. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|